Avanos Medical is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April. At this time, Avanos Medical's Common Stock Shares Outstanding is comparatively stable compared to the past year. Inventory is likely to gain to about 149.5 M in 2025, whereas Net Tangible Assets are likely to drop slightly above 181.9 M in 2025. Key indicators impacting Avanos Medical's financial strength include:
Investors should never underestimate Avanos Medical's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Avanos Medical's cash flow, debt, and profitability to make informed and accurate decisions about investing in Avanos Medical.
Net Income
(372.5 Million)
Avanos
Select Account or Indicator
Market Cap
Enterprise Value
Price To Sales Ratio
Ptb Ratio
Days Sales Outstanding
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Stock Based Compensation To Revenue
Capex To Depreciation
Pb Ratio
Ev To Sales
Free Cash Flow Per Share
Roic
Inventory Turnover
Net Income Per Share
Days Of Inventory On Hand
Payables Turnover
Sales General And Administrative To Revenue
Research And Ddevelopement To Revenue
Capex To Revenue
Cash Per Share
Pocfratio
Interest Coverage
Capex To Operating Cash Flow
Pfcf Ratio
Days Payables Outstanding
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Intangibles To Total Assets
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Receivables Turnover
Shareholders Equity Per Share
Debt To Equity
Capex Per Share
Graham Net Net
Revenue Per Share
Interest Debt Per Share
Debt To Assets
Enterprise Value Over E B I T D A
Graham Number
Short Term Coverage Ratios
Price Earnings Ratio
Operating Cycle
Price Book Value Ratio
Price Earnings To Growth Ratio
Days Of Payables Outstanding
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Pretax Profit Margin
Ebt Per Ebit
Operating Profit Margin
Effective Tax Rate
Company Equity Multiplier
Long Term Debt To Capitalization
Total Debt To Capitalization
Return On Capital Employed
Debt Equity Ratio
Ebit Per Revenue
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Net Income Per E B T
Cash Ratio
Cash Conversion Cycle
Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding
Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios
Price To Book Ratio
Fixed Asset Turnover
Capital Expenditure Coverage Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Debt Ratio
Cash Flow To Debt Ratio
Price Sales Ratio
Return On Assets
Asset Turnover
Net Profit Margin
Gross Profit Margin
Price Fair Value
Return On Equity
Change To Inventory
Change In Cash
Stock Based Compensation
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Other Cashflows From Financing Activities
Depreciation
Other Non Cash Items
Capital Expenditures
Total Cash From Operating Activities
Change To Account Receivables
Net Income
Total Cash From Financing Activities
End Period Cash Flow
Change To Netincome
Sale Purchase Of Stock
Change Receivables
Net Borrowings
Total Cashflows From Investing Activities
Exchange Rate Changes
Dividends Paid
Cash And Cash Equivalents Changes
Cash Flows Other Operating
Change To Operating Activities
Other Cashflows From Investing Activities
Change To Liabilities
Investments
Total Assets
Other Current Liab
Total Current Liabilities
Total Stockholder Equity
Other Liab
Net Tangible Assets
Retained Earnings
Accounts Payable
Cash
Other Assets
Long Term Debt
Net Receivables
Good Will
Retained Earnings Total Equity
Common Stock Shares Outstanding
Inventory
Other Current Assets
Other Stockholder Equity
Total Liab
Deferred Long Term Liab
Short Long Term Debt
Total Current Assets
Accumulated Other Comprehensive Income
Treasury Stock
Short Term Debt
Intangible Assets
Property Plant Equipment
Short Long Term Debt Total
Property Plant And Equipment Net
Current Deferred Revenue
Net Debt
Non Current Assets Total
Non Currrent Assets Other
Cash And Short Term Investments
Liabilities And Stockholders Equity
Non Current Liabilities Total
Property Plant And Equipment Gross
Long Term Debt Total
Capital Surpluse
Non Current Liabilities Other
Net Invested Capital
Net Working Capital
Capital Lease Obligations
Depreciation And Amortization
Interest Expense
Selling General Administrative
Total Revenue
Gross Profit
Other Operating Expenses
Operating Income
Ebit
Research Development
Ebitda
Cost Of Revenue
Total Operating Expenses
Income Before Tax
Total Other Income Expense Net
Income Tax Expense
Net Income Applicable To Common Shares
Discontinued Operations
Net Income From Continuing Ops
Non Operating Income Net Other
Tax Provision
Interest Income
Extraordinary Items
Net Interest Income
Reconciled Depreciation
Probability Of Bankruptcy
Understanding current and past Avanos Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Avanos Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in Avanos Medical's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Avanos Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Avanos Medical. Check Avanos Medical's Beneish M Score to see the likelihood of Avanos Medical's management manipulating its earnings.
Avanos Medical Stock Summary
Avanos Medical competes with Artivion, Anika Therapeutics, Sight Sciences, Orthofix Medical, and Axogen. Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia. Avanos Medical operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 4555 people.
The reason investors look at the income statement is to determine what Avanos Medical's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
Comparative valuation techniques use various fundamental indicators to help in determining Avanos Medical's current stock value. Our valuation model uses many indicators to compare Avanos Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Avanos Medical competition to find correlations between indicators driving Avanos Medical's intrinsic value. More Info.
Avanos Medical is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Avanos Medical's Return On Equity is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Avanos Medical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Avanos Medical Systematic Risk
Avanos Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Avanos Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Avanos Medical correlated with the market. If Beta is less than 0 Avanos Medical generally moves in the opposite direction as compared to the market. If Avanos Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Avanos Medical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Avanos Medical is generally in the same direction as the market. If Beta > 1 Avanos Medical moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Avanos Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Avanos Medical's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Avanos Medical growth as a starting point in their analysis.
Along with financial statement analysis, the daily predictive indicators of Avanos Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Avanos Medical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Avanos Medical based on widely used predictive technical indicators. In general, we focus on analyzing Avanos Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Avanos Medical's daily price indicators and compare them against related drivers.
When running Avanos Medical's price analysis, check to measure Avanos Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avanos Medical is operating at the current time. Most of Avanos Medical's value examination focuses on studying past and present price action to predict the probability of Avanos Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avanos Medical's price. Additionally, you may evaluate how the addition of Avanos Medical to your portfolios can decrease your overall portfolio volatility.